PRECISION BIOSCIENCES INC — Director's Dealing 2022

Oct 26, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-10-24

Reporting Person: Amoroso Michael (Director, President and CEO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-10-24	Stock Option (Right to Buy)	$1.38	A	250000	Acquired	2032-10-23	Common Stock (250000)	Direct

Footnotes

F1: The Reporting Person was granted stock options in accordance with the Reporting Person's employment agreement with the Issuer.

F2: The option vests as to 25% of the underlying shares on October 15, 2023 and thereafter in twelve substantially equal installments at the end of each three-month period over the 36 months following such date, subject to the Reporting Person's continued service to the Company through the applicable vesting dates.